feed,title,long_url,short_url
Benzinga,"JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients",https://benzinga.com/general/biotech/21/06/21545497/jnjs-imbruvica-abbvies-venclexta-combo-achieves-progression-free-survival-of-78-4-versus-gazyva-c,https://j.mp/3glOiyd
